Oncology Clinical Trials

TARPON SPRINGS, Fla., March 6, 2026 Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced the successful closing of...

RARITAN, N.J., Feb. 19, 2026 — Johnson & Johnson announced new Phase 1b/2 clinical data demonstrating that subcutaneous RYBREVANT...

BOSTON, Mass., Feb. 20, 2026 — New clinical findings presented at a major oncology symposium demonstrate that ficerafusp alfa...

LEXINGTON, Mass., Feb. 19, 2026 — Agenus Inc. announced new translational and clinical biomarker findings demonstrating survival stratification in...

DUBLIN, IRELAND | January 27, 2026 — ICON plc, a global clinical research organization, announced a significant expansion of...

WESTLAKE VILLAGE, Calif. | January 5, 2026 — Genelux Corporation, a late clinical-stage immuno-oncology company, has reported encouraging interim...

BARCELONA, Spain, Oct. 8, 2025 — During the 2025 Annual Congress of the European Association of Nuclear Medicine (EANM...